Mir­ror­ing Sen­ate coun­ter­parts, House com­mit­tee ad­vances PBM re­forms

The House En­er­gy & Com­merce Com­mit­tee ad­vanced mul­ti­ple bills to the House floor in a sev­en-hour hear­ing Wednes­day, some of which in­clud­ed mea­sures to ad­dress drug pric­ing trans­paren­cy and PBMs.

The high­lights in­clud­ed two bills, among oth­er health­care mea­sures, that would ad­vance ac­count­abil­i­ty around PBMs and on drug pric­ing, in­clud­ing the em­bat­tled 340B pro­gram. One bill, al­so known as the “Pro­mot­ing Ac­cess to Treat­ments and In­creas­ing Ex­treme­ly Need­ed Trans­paren­cy,” or PA­TIENT Act, would ban spread pric­ing where PBMs can charge a state more than they re­im­burse phar­ma­cies. That same ban was in­clud­ed in a Sen­ate bill that al­so re­cent­ly ad­vanced out of com­mit­tee.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER